
Lipocine LPCN
€ 1.34
-3.29%
Lipocine DSO | LPCN
DSO Jährlich Lipocine
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 3.76 M | 36.6 | 32.8 | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.76 M | 32.8 | 1.25 M |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Trillium Therapeutics Inc.
TRIL
|
2.34 K | - | - | $ 1.94 B | ||
|
Acceleron Pharma Inc.
XLRN
|
42.2 | - | - | $ 10.9 B | ||
|
Zogenix, Inc.
ZGNX
|
102 | - | -4.97 % | $ 664 M | ||
|
ZIOPHARM Oncology, Inc.
ZIOP
|
4.66 K | - | -7.58 % | $ 264 M | ||
|
Vericel Corporation
VCEL
|
96.5 | $ 57.41 | -1.46 % | $ 2.89 B | ||
|
Vir Biotechnology
VIR
|
9.84 | $ 8.37 | -5.64 % | $ 1.16 B | ||
|
Veracyte
VCYT
|
32.2 | $ 25.08 | 0.16 % | $ 1.97 B | ||
|
Vanda Pharmaceuticals
VNDA
|
85.9 | $ 3.44 | -6.27 % | $ 203 M | ||
|
VistaGen Therapeutics
VTGN
|
0.0312 | $ 0.16 | -12.33 % | $ 6.09 M | ||
|
Voyager Therapeutics
VYGR
|
14.8 | $ 1.52 | -5.9 % | $ 89.2 M | ||
|
Verrica Pharmaceuticals
VRCA
|
27.2 | $ 2.74 | -5.03 % | $ 29.2 M | ||
|
Wave Life Sciences Ltd.
WVE
|
11.5 | $ 2.56 | -6.07 % | $ 432 M | ||
|
XBiotech
XBIT
|
40.8 | $ 1.75 | 4.17 % | $ 53.4 M | ||
|
XTL Biopharmaceuticals Ltd.
XTLB
|
65.6 | $ 1.37 | -7.43 % | $ 922 M | ||
|
ADMA Biologics
ADMA
|
74.6 | $ 13.18 | -1.2 % | $ 3.14 B | ||
|
Exicure
XCUR
|
-4.16 | $ 0.96 | -7.24 % | $ 6.05 M | ||
|
Xencor
XNCR
|
131 | $ 33.48 | -1.56 % | $ 2.49 B | ||
|
Daré Bioscience
DARE
|
877 | $ 0.41 | -9.93 % | $ 4.58 M | ||
|
Fate Therapeutics
FATE
|
122 | $ 0.92 | -9.07 % | $ 109 M | ||
|
Halozyme Therapeutics
HALO
|
93.4 | $ 91.28 | -1.89 % | $ 10.9 B | ||
|
Hutchison China MediTech Limited
HCM
|
93.9 | $ 13.18 | -2.04 % | $ 11.3 B | ||
|
Aptorum Group Limited
APM
|
94 | - | - | $ 5.72 M | ||
|
iBio
IBIO
|
138 | $ 0.83 | 3.01 % | $ 86.4 M | ||
|
Karyopharm Therapeutics
KPTI
|
71.1 | $ 0.02 | -56.5 % | $ 219 | ||
|
FSD Pharma
HUGE
|
2.94 K | - | 5743.5 % | $ 69.7 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
59.5 | - | - | $ 3.85 B | ||
|
UroGen Pharma Ltd.
URGN
|
88.7 | $ 28.91 | -8.89 % | $ 1.39 B | ||
|
Catalyst Biosciences
CBIO
|
79.3 | $ 13.01 | 0.74 % | $ 1.16 B | ||
|
ADiTx Therapeutics
ADTX
|
6.94 K | - | - | $ 374 | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Apellis Pharmaceuticals
APLS
|
115 | - | - | $ 5.18 B |